UnitedHealth Group Inc UNH
Start på sektionStart på sektionSeneste
521,27
Kursændring
3,72|0,72%
Data opdateret pr. 16-05-2024
19:56:47 EDT | USD
Minimum 15 minutters forsinkelse.
Slut på sektion Start på sektionBud/Udbud | Dagens kursspænd | Omsætning | 3mGnsOms | Markedsværdi |
---|
521,10 - 523,00 | 519,51 - 528,16 | 3.655.775 | 4.334.035 | 479,80Mia. |
Slut på sektionStart på sektionSeneste luk | 52 ugers spænd | P/E | Udbytte | ISIN |
---|
517,55 | 436,38 - 554,70 | 31,60 | 1,45 | US91324P1021 |
Slut på sektion Slut på sektionStart på sektionSlut på sektionMr. Lee Davidson, Head of Quantitative Research
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click
here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click
here. Start på sektion | 2021 | 2022 | 2023 |
---|
Mere |
Omsætning | 287.597,00 | 324.162,00 | 371.622,00 |
---|
Resultat før skat | 23.970,00 | 28.435,00 | 32.358,00 |
---|
Årets resultat | 17.285,00 | 20.120,00 | 22.381,00 |
---|
Årets resultat pr. aktie | 18,33 | 21,47 | 24,12 |
---|
Gns. aktiekapital - udvandet | 956 | 950 | 938 |
---|
Omsætningsaktiver | 61.758,00 | 69.069,00 | 78.437,00 |
---|
Anlægsaktiver | 150.448,00 | 176.636,00 | 195.283,00 |
---|
Aktiver i alt | 212.206,00 | 245.705,00 | 273.720,00 |
---|
Kortfristet gæld | 78.292,00 | 89.237,00 | 99.054,00 |
---|
Forpligtelser i alt | - | - | - |
---|
Egenkapital | 71.760,00 | 77.772,00 | 88.756,00 |
---|
Pengestrømme fra driften | 22.343,00 | 26.206,00 | 29.068,00 |
---|
Anlægsinvesteringer | -2.454,00 | -2.802,00 | -3.386,00 |
---|
Frie pengestrømme | 19.889,00 | 23.404,00 | 25.682,00 |
---|
Slut på sektionI mio., undtagen årets resultat pr. aktie. Valuta er USD.
Profil
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 53 million members globally, including 5 million outside the U.S. as of mid-2023. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Start på sektionMere |
P/E - Kurs/indtjening (sidste 12m) | 31,22 |
---|
P/B - Kurs/indre værdi | 5,49 |
---|
P/S - Kurs/omsætning (sidste 12m) | 1,27 |
---|
Omsætningsvækst (3 års gns) | 13,06 |
---|
Vækst i indtj. pr. aktie (3 års gns) | - |
---|
Indtjeningsgrad i % (sidste 12m) | 8,71 |
---|
Overskudsgrad i % (sidste 12m) | 6,02 |
---|
Egenkapitalforrentning (sidste 12m) | 26,88 |
---|
Gæld/egenkapital | 0,66 |
---|
Slut på sektionStart på sektion | Forrige | Seneste |
---|
|
Erklæringsdato | 08-11-23 | 23-02-24 |
---|
Ex. udbyttedato | 01-12-23 | 08-03-24 |
---|
Udbetalingsdato | 12-12-23 | 19-03-24 |
---|
Udbytte pr. aktie | 1,88 | 1,88 |
---|
Slut på sektion